CVR Energy to Release Third Quarter 2024 Earnings Results
SUGAR LAND, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) -- (NYSE: CVI) plans to release its third quarter 2024 earnings results on ...
bovnews1d
CVR Energy, Inc. (CVI) Stock: A Deeper Look at Its True Potential
On Tuesday, CVR Energy, Inc. (CVI) stock saw a decline, ending the day at $23.19 which represents a decrease of $-1.43 or -5.81% from the prior close of $24.62. The stock opened at $24.19 and touched ...
CVR Partners to Release Third Quarter 2024 Earnings Results
CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans ...
AQR Capital Management LLC Has $1.43 Million Stock Position in CVR Energy, Inc. (NYSE:CVI)
AQR Capital Management LLC increased its stake in shares of CVR Energy, Inc. (NYSE:CVI – Free Report) by 223.6% during the ...
CVR Partners, LP (UAN): Another Bull Case Theory
We came across a bullish thesis on CVR Partners, LP (UAN) on Triple S Special Situations Investing’s Substack by TripleS ...
bovnews5d
What’s Causing CVR Energy, Inc. (CVI) Stock’s -29.45% Drop Over the Last Six Months?
On Friday, CVR Energy, Inc. (CVI) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.16 or 0.65% from the prior close of $24.63. The stock opened at $24.46 ...
The Manufacturers Life Insurance Company Has $979,000 Stock Holdings in CVR Energy, Inc. (NYSE:CVI)
The Manufacturers Life Insurance Company grew its stake in CVR Energy, Inc. (NYSE:CVI – Free Report) by 7.2% during the second quarter, HoldingsChannel.com reports. The firm owned 36,562 shares of the ...
TuHURA Biosciences, Inc.: TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics
Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapyLead program entering single Phase 3 accelerated appr ...
Mixed Signals Lead to Hold Rating on Occidental Petroleum Amid Financial and Operational Uncertainties
Mizuho Securities analyst Nitin Kumar CFA has reiterated their neutral stance on OXY stock, giving a Hold rating yesterday. Nitin Kumar CFA ...
Deals: The Economic Structure of Business Transactions
The Economic Structure of Business Transactions is a collaboration between academics who offered a course of the same name at ...
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential
Piper Sandler has initiated coverage on ANI Pharmaceuticals, emphasizing its strategic shift towards high-margin brand assets, particularly the successful Cortrophin Gel, which has seen substantial ...
Zacks Small Cap Research on MSN3d
DWTX: Virios Therapeutics Becomes Dogwood Therapeutics; Focus on Chemotherapy-Induced Neuropathic Pain…
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Virios Combines with Wex Pharmaceuticals to Form Dogwood Therapeutics ...